News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...
GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.
FOX 13 Seattle on MSN13h
Navigating weight loss drug coverage changesHealth insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...
14h
inews.co.uk on MSNWeight loss jabs to be given to 3,000 people in trial to get them back into workWeight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...
18hon MSN
Wall Street hits record highs as payrolls surge. Explore healthcare stock movers, obesity drug breakthroughs, AbbVie deals, Centene struggles & ...
The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results